Sanofi SA:企業の戦略・SWOT・財務情報

◆英語タイトル:Sanofi SA - Strategy, SWOT and Corporate Finance Report
◆商品コード:DATA904C4425
◆発行会社(調査会社):MarketLine
◆発行日:2018年8月
◆ページ数:61
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD175 ⇒換算¥25,900見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD350 ⇒換算¥51,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD525 ⇒換算¥77,700見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はMarketLine社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
MarketLine社の概要はこちらでご確認いただけます。



【レポートの概要】

Sanofi SA – Strategy, SWOT and Corporate Finance Report
Summary

Sanofi SA – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Key Highlights

Sanofi SA (Sanofi or ‘the group’) is a France-based international pharmaceutical group engaged in research, development, manufacture and marketing of healthcare products. The group offers a range of products related to rare diseases, multiple sclerosis, oncology, diabetes, and cardiovascular diseases. In addition, it provides prescription products, consumer healthcare products, generics, and vaccines. It offers products related to Vaccines that include pediatric vaccines for diphtheria, tetanus, pertussis, polio and haemophilus influenzae type b (Hib), influenza vaccines and adult and adolescent booster vaccines. The group operates across North America and Europe. Sanofi is headquartered in Paris, France.

Scope

- Detailed information on Sanofi SA required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Sanofi SA in the form of a SWOT analysis
- An in-depth view of the business model of Sanofi SA including a breakdown and examination of key business segments
- Intelligence on Sanofi SA’s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Sanofi SA, such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

- Gain understanding of Sanofi SA and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Sanofi SA as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers’ businesses better.
- Stay up to date on Sanofi SA’s business structure, strategy and prospects.

【レポートの目次】

Table of Contents
Company Snapshot 2
Table of Contents 5
Sanofi SA: Company Overview 9
Sanofi SA: Overview and Key Facts 9
Sanofi SA: Overview 9
Sanofi SA: Key Facts 9
Sanofi SA: Key Employees 11
Sanofi SA: Key Employee Biographies 13
Sanofi SA: Major Products and Services 14
Sanofi SA: Company History 15
Sanofi SA: Management Statement 27
Sanofi SA: Locations and Subsidiaries 29
Sanofi SA: Key Competitors 30
Sanofi SA: Company Analysis 31
Sanofi SA: Business Description 31
Sanofi SA: SWOT Analysis 33
Sanofi SA: SWOT Overview 33
Sanofi SA: Strengths 33
Sanofi SA: Weaknesses 34
Sanofi SA: Opportunities 34
Sanofi SA: Threats 34
Sanofi SA: Corporate Financial Deals Activity 37
Sanofi SA: Financial Deals Overview 37
Sanofi SA: Targets and Partners 39
Sanofi SA: Top Deals 2014 – 2018YTD* 42
Sanofi SA: Advisors 43
Sanofi SA: Top Legal Advisors 43
Sanofi SA: Top Financial Advisors 43
Sanofi SA: Mergers and Acquisitions 45
Sanofi SA: Corporate Venturing 46
Sanofi SA: Capital Raising 47
Sanofi SA: Partnership 48
Sanofi SA: Divestments 49
Sanofi SA: Recent Developments 50
Sanofi SA: News and Events Summary 50
Sanofi SA: Business Expansion 54
Sanofi SA: Contracts 55
Sanofi SA: Corporate Governance 56
Sanofi SA: Financial Deals 57
Sanofi SA: Regulatory and Legal Events 57
Sanofi SA: Strategy and Operations 58
Appendix 59
Contact Us 59
Methodology 59
About MarketLine 60

List of Tables
Table 1: Sanofi SA: Key Facts
Table 2: Sanofi SA: Key Employees
Table 3: Sanofi SA: Locations and Subsidiaries
Table 4: Sanofi SA: Key Competitors
Table 5: Sanofi SA: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Sanofi SA: M&A Activity by Geography (TTM*)
Table 7: Sanofi SA: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Table 8: Sanofi SA: M&A Average Deal Size - Value (US$m)
Table 9: Sanofi SA: Targets and Partners
Table 10: Sanofi SA: Top Deals 2014 - 2018YTD*
Table 11: Sanofi SA: Legal Advisor Ranking by Value (US$m)
Table 12: Sanofi SA: Financial Advisor Ranking by Value (US$m)
Table 13: Sanofi SA: M&A Volume and Value Trend (2014 - YTD*2018)
Table 14: Sanofi SA: M&A Activity by Geography (2014 - YTD*2018)
Table 15: Sanofi SA: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Table 16: Sanofi SA: Corporate Venturing by Geography (2014 - YTD*2018)
Table 17: Sanofi SA: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Table 18: Sanofi SA: Capital Raising by Deal Type (2014 - YTD*2018)
Table 19: Sanofi SA: Partnership Volume and Value Trend (2014 - YTD*2018)
Table 20: Sanofi SA: Partnership Trend by Deal Type (2014 - YTD*2018)
Table 21: Sanofi SA: Divestments Volume and Value Trend (2014 - YTD*2018)
Table 22: Sanofi SA: Divestments by Geography (2014 - YTD*2018)
Table 23: Sanofi SA: News and Events Summary
Table 24: Sanofi SA: Business Expansion
Table 25: Sanofi SA: Contracts
Table 26: Sanofi SA: Corporate Governance
Table 27: Sanofi SA: Financial Deals
Table 28: Sanofi SA: Regulatory and Legal Events
Table 29: Sanofi SA: Strategy and Operations

List of Figures
Figure 1: Sanofi SA: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Sanofi SA: M&A Activity by Geography (TTM*)
Figure 3: Sanofi SA: Deal Activity by Deal Type - Volume (2014 - YTD*2018)
Figure 4: Sanofi SA: M&A Average Deal Size - Value (US$m)
Figure 5: Sanofi SA: M&A Volume and Value Trend (2014 - YTD*2018)
Figure 6: Sanofi SA: M&A Activity by Geography (2014 - YTD*2018)
Figure 7: Sanofi SA: Corporate Venturing Volume and Value Trend (2014 - YTD*2018)
Figure 8: Sanofi SA: Corporate Venturing by Geography (2014 - YTD*2018)
Figure 9: Sanofi SA: Capital Raising Volume and Value Trend (2014 - YTD*2018)
Figure 10: Sanofi SA: Capital Raising by Deal Type (2014 - YTD*2018)
Figure 11: Sanofi SA: Partnership Volume and Value Trend (2014 - YTD*2018)
Figure 12: Sanofi SA: Partnership Trend by Deal Type (2014 - YTD*2018)
Figure 13: Sanofi SA: Divestments Volume and Value Trend (2014 - YTD*2018)
Figure 14: Sanofi SA: Divestments by Geography (2014 - YTD*2018)

★海外企業調査レポート[Sanofi SA:企業の戦略・SWOT・財務情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • China Haisheng Juice Holdings Co Ltd:戦略・SWOT・企業財務分析
    China Haisheng Juice Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report Summary China Haisheng Juice Holdings Co Ltd - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • New Standard Energy Ltd (NSE):企業の財務・戦略的SWOT分析
    Summary New Standard Energy Ltd (NSE), formerly Hawk Resources Ltd, is an oil and gas exploration and production company. The company carries out acquisition, exploration, and develops oil and gas; and hydrocarbon properties. It holds interest in production and development project in the Eagle Ford …
  • Kura Oncology Inc (KURA):企業の財務・戦略的SWOT分析
    Summary Kura Oncology Inc (Kura Oncology) is a clinical-stage biopharmaceutical company that discovers and develops therapeutics for the treatment of solid tumors and blood cancers. The company’s lead drug candidate Tipifarnib, an inhibitor of farnesyl transferase, an oral investigational drug candi …
  • PDF Solutions Inc (PDFS):企業の財務・戦略的SWOT分析
    Summary PDF Solutions Inc (PDF Solutions) is a technology company that offers yield improvement technologies and services for the IC manufacturing process life cycle. The company offers products such as Exensio Control, Exensio Yield, Exensio Test, Exensio Char, Yield Ramp Simulator and Circuit Surf …
  • Varta AG (VAR1):企業の財務・戦略的SWOT分析
    Varta AG (VAR1) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the p …
  • The Kraft Heinz Co:企業のM&A・事業提携・投資動向
    The Kraft Heinz Co - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's The Kraft Heinz Co Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • genedrive plc (GDR):企業の財務・戦略的SWOT分析
    genedrive plc (GDR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and t …
  • Lensar Inc-医療機器分野:企業M&A・提携分析
    Summary Lensar Inc (Lensar), a subsidiary of Alphaeon Corp is a medical device company that designs, develops and manufactures laser and advanced 3D imaging technology and devices for refractive cataract surgery. The company provides surgeon with superior femtosecond laser technology. It offers vari …
  • Delta Apparel, Inc. (DLA):企業の財務・戦略的SWOT分析
    Delta Apparel, Inc. (DLA) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • SSP Group Limited (Foodservice):企業の戦略・SWOT・財務情報
    SSP Group Limited (Foodservice) - Strategy, SWOT and Corporate Finance Report Summary SSP Group Limited (Foodservice) - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Mitsubishi Research Institute Inc (3636):企業の財務・戦略的SWOT分析
    Mitsubishi Research Institute Inc (3636) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths …
  • NSD Co Ltd (9759):企業の財務・戦略的SWOT分析
    NSD Co Ltd (9759) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • Laureate Education, Inc.:企業のM&A・事業提携・投資動向
    Laureate Education, Inc. - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Laureate Education, Inc. Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisiti …
  • Siemens Healthineers AG (SHL):企業の財務・戦略的SWOT分析
    Siemens Healthineers AG (SHL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Egmont International Holding AS:企業の戦略的SWOT分析
    Egmont International Holding AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Saudi Arabian Mining Co:戦略・SWOT・企業財務分析
    Saudi Arabian Mining Co - Strategy, SWOT and Corporate Finance Report Summary Saudi Arabian Mining Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Metabolomic Technologies Inc-医療機器分野:企業M&A・提携分析
    Summary Metabolomic Technologies Inc (MTI) is a biotechnology company that develops metabolomic-based diagnostic systems. The company's products comprise ColoDx, PolypDx, BreastDx, ProstateDx, CeliacDx, ColitisDx, CrohnsDx and other products. Its products develop advanced diagnostic tests for gastro …
  • Berner Oberland-Bahnen AG:企業の戦略・SWOT・財務情報
    Berner Oberland-Bahnen AG - Strategy, SWOT and Corporate Finance Report Summary Berner Oberland-Bahnen AG - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • I Grandi Viaggi Spa
    I Grandi Viaggi Spa - Strategy, SWOT and Corporate Finance Report Summary I Grandi Viaggi Spa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • NGL Energy Partners LP:企業の戦略・SWOT・財務情報
    NGL Energy Partners LP - Strategy, SWOT and Corporate Finance Report Summary NGL Energy Partners LP - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆